Mavacamten in adults with symptomatic obstructive HCM who are eligible for septal reduction therapy (VALOR-HCM) Milind Y. Desai, Kathy Wolski, Anjali
Mavacamten in adults with symptomatic obstructive HCM who are eligible for septal reduction therapy (VALOR-HCM) Milind Y. Desai, Kathy Wolski, Anjali
A new Rx for an uncommon disease